Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 15
Encontrada(s) 1 página(s)

Biblos-e Archivo. Repositorio Institucional de la UAM
Publicación Artículo científico (JournalArticle)

Regulation of SNAIL1 and E-cadherin function by DNMT1 in a DNA methylation-independent context

  • Espada, Jesús M.
  • Peinado, Héctor
  • Lopez-Serra, Lidia
  • Setién, Fernando
  • López-Serra, Paula
  • Portela, Anna
  • Renart, Jaime
  • Calvo, María Isabel
  • Juarranz de la Fuente, Ángeles
  • Cano, Amparo
  • Esteller, Manel Asunción Alsina
  • Carrasco Cerro, Elisa
Mammalian DNA methyltransferase 1 (DNMT1) is essential for maintaining DNA methylation patterns after cell division. Disruption of DNMT1 catalytic activity results in whole genome cytosine demethylation of CpG dinucleotides, promoting severe dysfunctions in somatic cells and during embryonic development. While these observations indicate that DNMT1-dependent DNA methylation is required for proper cell function, the possibility that DNMT1 has a role independent of its catalytic activity is a matter of controversy. Here, we provide evidence that DNMT1 can support cell functions that do not require the C-terminal catalytic domain. We report that PCNA and DMAP1 domains in the N-terminal region of DNMT1 are sufficient to modulate E-cadherin expression in the absence of noticeable changes in DNA methylation patterns in the gene promoters involved. Changes in E-cadherin expression are directly associated with regulation of β-catenin-dependent transcription. Present evidence suggests that the DNMT1 acts on E-cadherin expression through its direct interaction with the E-cadherin transcriptional repressor SNAIL1, MEC (SAF2008-00609 to J.E.); MEC (SAF2007-63051 and Consolider CSD2007-00017); EU (MRTN-CT-2004- 005428 to A.C.); MEC (SAF2004-07729, Consolider CSD2006-49); EU (FP7-CANCERDIP-2007-200620 to M.E.); MEC (SAF2010-19152 to J.R.). M.E. is an ICREA Research Professor. J.E. is a Ramon y Cajal Program researcher (MICIIN). Funding for open access charge: Consolider CSD2006-49 (Grant of the Spanish Science Governmental Department)
Docta Complutense
Publicación Artículo científico (JournalArticle)

Assessing vulnerability of reptile hotspots through temporal trends of global change factors in the Iberian Peninsula

  • Tarjuelo, Rocío
  • Aragón Carrera, Pedro
Habitat degradation and climate change are major threats to the long-term persistence of reptile populations. However, their roles on primary productivity instability remain unclear at certain scales. Besides, the design of protected areas has often overlooked reptiles or assumed that their ecological requirements are represented under the umbrella of more charismatic species. Here, we assess the vulnerability of areas of high diversity of reptiles in the Iberian Peninsula to global change using data from satellite imagery. We focused on primary productivity, climate and land-use change because they are indicators of environmental variability that might impair ecosystem functioning and alter wildlife communities. We used linear regressions to detect monotonic temporal trends in primary productivity (through the enhanced vegetation index, EVI) and climate (mean temperature and accumulated precipitation) at two spatial resolutions (10-km2 UTM squares and CORINE land-cover polygon level) over the period 2000–2020. We also determined how the strength of land-use and climate change affected the intensity of change in primary productivity at both spatial scales with multivariate linear regressions. We identified 339 hotspots (10-km2 UTM squares) and monotonic increments of temperature, EVI or both occurred in 43 %, 16 % and 22 % of them, respectively. Positive trends of the EVI were related to increasing temperatures and changes in shrubland and forest cover. Within the hotspots with monotonic increments in EVI and temperature, EVI increments occurred in 65 % of the CORINE polygons that did not change their land-cover type, with stronger increases in tree crops. Finally, the Natura 2000 network provides only moderate protection to reptile hotspots, being most of the vegetation types relatively underrepresented. The proportion of forest and shrubland protected by the Natura 2000 network was higher in hotspots where EVI changed. Our procedures are relevant to prioritize hotspots requiring ground monitoring that allows economic and time savings.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

A DNA methylation fingerprint of 1628 human samples

  • Pérez Jurado, Luis Alberto
  • Fernández, Agustín F.
  • Esteller, Manel
Most of the studies characterizing DNA methylation patterns have been restricted to particular genomic loci in a limited number of human samples and pathological conditions. Herein, we present a compromise between an extremely comprehensive study of a human sample population with an intermediate level of resolution of CpGs at the genomic level. We obtained a DNA methylation fingerprint of 1628 human samples in which we interrogated 1505 CpG sites. The DNA methylation patterns revealed show this epigenetic mark to be critical in tissue-type definition and stemness, particularly around transcription start sites that are not within a CpG island. For disease, the generated DNA methylation fingerprints show that, during tumorigenesis, human cancer cells underwent a progressive gain of promoter CpG-island hypermethylation and a loss of CpG methylation in non-CpG-island promoters. Although transformed cells are those in which DNA methylation disruption is more obvious, we observed that other common human diseases, such as neurological and autoimmune disorders, had their own distinct DNA methylation profiles. Most importantly, we provide proof of principle that the DNA methylation fingerprints obtained might be useful for translational purposes by showing that we are able to identify the tumor type origin of cancers of unknown primary origin (CUPs). Thus, the DNA methylation patterns identified across the largest spectrum of samples, tissues, and diseases reported to date constitute a baseline for developing higher-resolution DNA methylation maps and provide important clues concerning the contribution of CpG methylation to tissue identity and its changes in the most prevalent human diseases., This work was supported by European Grants CANCER DIP HEALTH-F2-2007-200620, LSHG-CT-2006-018739-ESTOOLS, LSHC-CT-2006-037297- MCSCs, the Dr. Josef Steiner Cancer Research Foundation Award, the Fondo de Investigaciones Sanitarias Grant PI08-1345, Consolider Grant MEC09-05, the Spanish Association Against Cancer (AECC), Spanish Ministry of Education and Science (SAF2009-07319), the Lilly Foundation Biomedical ResearchAward, Fundació Cellex, and the Health Department of the Catalan Government (Generalitat de Catalunya). R.S. is supported by BMBF and Deutsche Krebshilfe. J.B. is supported in part by the University College London Cancer Institute Experimental Cancer Medicine Centre and the University College London Hospitals and University College London Comprehensive Biomedical Research Centre. M.E. is an Institució Catalana de Recerca i Estudis Avançats (ICREA) Research Professor
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

A DNA methylation fingerprint of 1628 human samples

  • Fernández, Agustín F.
  • Martín-Subero, José Ignacio
  • Hidalgo, Manuel
  • Ferrer, Isidro (Ferrer Abizanda)
  • Sánchez Céspedes, Montserrat
  • Villanueva Garatachea, Alberto
  • Carmona, F. Javier
  • Sanchez-Mut, Jose Vicente
  • Berdasco, María
  • Moreno Aguado, Víctor
  • Capellá, G. (Gabriel)
  • Ballestar Tarín, Esteban
  • Pérez Jurado, Luis A.
  • Mora Graupera, Jaume
  • Puig i Sardà, Susana
  • Prat, Jaime
  • Badimón, Lina, 1953-
  • Esteller, Manel, 1968-
Most of the studies characterizing DNA methylation patterns have been restricted to particular genomic loci in a limited number of human samples and pathological conditions. Herein, we present a compromise between an extremely comprehensive study of a human sample population with an intermediate level of resolution of CpGs at the genomic level. We obtained a DNA methylation fingerprint of 1628 human samples in which we interrogated 1505 CpG sites. The DNA methylation patterns revealed show this epigenetic mark to be critical in tissue-type definition and stemness, particularly around transcription start sites that are not within a CpG island. For disease, the generated DNA methylation fingerprints show that, during tumorigenesis, human cancer cells underwent a progressive gain of promoter CpG-island hypermethylation and a loss of CpG methylation in non-CpG-island promoters. Although transformed cells are those in which DNA methylation disruption is more obvious, we observed that other common human diseases, such as neurological and autoimmune disorders, had their own distinct DNA methylation profiles. Most importantly, we provide proof of principle that the DNA methylation fingerprints obtained might be useful for translational purposes by showing that we are able to identify the tumor type origin of cancers of unknown primary origin (CUPs). Thus, the DNA methylation patterns identified across the largest spectrum of samples, tissues, and diseases reported to date constitute a baseline for developing higher-resolution DNA methylation maps and provide important clues concerning the contribution of CpG methylation to tissue identity and its changes in the most prevalent human diseases
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

The RNA-binding protein HuR regulates DNA methylation through stabilization of DNMT3b mRNA

  • López de Silanes, Isabel
  • Gorospe, Myriam
  • Taniguchi, Hiroaki
  • Abdelmohsen, Kotb
  • Srikantan, Subramanya
  • Alaminos, Miguel
  • Berdasco, María
  • Urdinguio, Rocío G.
  • Fraga, Mario F.
  • Jacinto, Filipe V.
  • Esteller, Manel, 1968-
The molecular basis underlying the aberrant DNA-methylation patterns in human cancer is largely unknown. Altered DNA methyltransferase (DNMT) activity is believed to contribute, as DNMT expression levels increase during tumorigenesis. Here, we present evidence that the expression of DNMT3b is post-transcriptionally regulated by HuR, an RNA-binding protein that stabilizes and/or modulates the translation of target mRNAs. The presence of a putative HuR-recognition motif in the DNMT3b 3UTR prompted studies to investigate if this transcript associated with HuR. The interaction between HuR and DNMT3b mRNA was studied by immunoprecipitation of endogenous HuR ribonucleoprotein complexes followed by RTqPCR detection of DNMT3b mRNA, and by in vitro pulldown of biotinylated DNMT3b RNAs followed by western blotting detection of HuR. These studies revealed that binding of HuR stabilized the DNMT3b mRNA and increased DNMT3b expression. Unexpectedly, cisplatin treatment triggered the dissociation of the [HuR-DNMT3b mRNA] complex, in turn promoting DNMT3b mRNA decay, decreasing DNMT3b abundance, and lowering the methylation of repeated sequences and global DNA methylation. In summary, our data identify DNMT3b mRNA as a novel HuR target, present evidence that HuR affects DNMT3b expression levels post-transcriptionally, and reveal the functional consequences of the HuR-regulated DNMT3b upon DNA methylation patterns.
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

Regulation of SNAIL1 and E-cadherin function by DNMT1 in a DNA methylation-independent context

  • Espada, Jesús
  • Peinado, Hector
  • Lopez Serra, Lidia
  • Setién, Fernando
  • López Serra, Paula
  • Portela, Anna
  • Renart, Jaime
  • Carrasco, Elisa
  • Calvo Ademuz, Maria
  • Juarranz, Angeles
  • Cano, Amparo
  • Esteller, Manel, 1968-
Mammalian DNA methyltransferase 1 (DNMT1) is essential for maintaining DNA methylation patterns after cell division. Disruption of DNMT1 catalytic activity results in whole genome cytosine demethylation of CpG dinucleotides, promoting severe dysfunctions in somatic cells and during embryonic development. While these observations indicate that DNMT1-dependent DNA methylation is required for proper cell function, the possibility that DNMT1 has a role independent of its catalytic activity is a matter of controversy. Here, we provide evidence that DNMT1 can support cell functions that do not require the C-terminal catalytic domain. We report that PCNA and DMAP1 domains in the N-terminal region of DNMT1 are sufficient to modulate E-cadherin expression in the absence of noticeable changes in DNA methylation patterns in the gene promoters involved. Changes in E-cadherin expression are directly associated with regulation of beta-catenin-dependent transcription. Present evidence suggests that the DNMT1 acts on E-cadherin expression through its direct interaction with the E-cadherin transcriptional repressor SNAIL1.
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

CpG island hypermethylation-associated silencing of non-coding RNAs transcribed from ultraconserved regions in human cancer

  • Lujambio, Amaia
  • Portela, Anna
  • Liz, Julia
  • Melo, Sónia Rita Cardoso, 1978-
  • Rossi, Simone
  • Spizzo, Riccardo
  • Croce, Carlo M.
  • Calin, George A.
  • Esteller, Manel, 1968-
Although only 1.5% of the human genome appears to code for proteins, much effort in cancer research has been devoted to this minimal fraction of our DNA. However, the last few years have witnessed the realization that a large class of non-coding RNAs (ncRNAs), named microRNAs, contribute to cancer development and progression by acting as oncogenes or tumor suppressor genes. Recent studies have also shown that epigenetic silencing of microRNAs with tumor suppressor features by CpG island hypermethylation is a common hallmark of human tumors. Thus, we wondered whether there were other ncRNAs undergoing aberrant DNA methylation-associated silencing in transformed cells. We focused on the transcribed-ultraconserved regions (T-UCRs), a subset of DNA sequences that are absolutely conserved between orthologous regions of the human, rat and mouse genomes and that are located in both intra- and intergenic regions. We used a pharmacological and genomic approach to reveal the possible existence of an aberrant epigenetic silencing pattern of T-UCRs by treating cancer cells with a DNA-demethylating agent followed by hybridization to an expression microarray containing these sequences. We observed that DNA hypomethylation induces release of T-UCR silencing in cancer cells. Among the T-UCRs that were reactivated upon drug treatment, Uc.160+, Uc283+A and Uc.346+ were found to undergo specific CpG island hypermethylation-associated silencing in cancer cells compared with normal tissues. The analysis of a large set of primary human tumors (n=283) demonstrated that hypermethylation of the described T-UCR CpG islands was a common event among the various tumor types. Our finding that, in addition to microRNAs, another class of ncRNAs (T-UCRs) undergoes DNA methylation-associated inactivation in transformed cells supports a model in which epigenetic and genetic alterations in coding and non-coding sequences cooperate in human tumorigenesis.
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer

  • Fernández, Agustín F.
  • Rosales, Cecilia
  • López Nieva, Pilar
  • Graña Castro, Osvaldo
  • Ballestar Tarín, Esteban
  • Ropero, Santiago
  • Espada, Jesús
  • Melo, Sónia Rita Cardoso, 1978-
  • Lujambio, Amaia
  • Fraga, Mario F.
  • Pino, Irene
  • Javierre, Biola M.
  • Carmona Herrera, Francisco
  • Acquadro, Francesco
  • Steenbergen, Renske D.M.
  • Snijders, Peter J. F.
  • Meijer, Chris J. L. M.
  • Pineau, Pascal
  • Dejean, Anne
  • Lloveras Rubio, Betlem
  • Capellá, G. (Gabriel)
  • Quer, Josep
  • Buti, Maria
  • Esteban, Juan I.
  • Allende, Helena
  • Rodríguez-Frías, Francisco
  • Castellsagué, Xavier
  • Minarovits, Janos
  • Ponce i Sebastià, Jordi
  • Capello, Daniela
  • Gaidano, Gianluca
  • Cigudosa, Juan Cruz
  • Gómez López, Gonzalo
  • Pisano, David G.
  • Valencia, Alfonso
  • Piris, Miguel A.
  • Bosch José, Francesc Xavier, 1947-
  • Cahir-McFarland, Ellen
  • Kieff, Elliott
  • Esteller, Manel, 1968-
The natural history of cancers associated with virus exposure is intriguing, since only a minority of human tissues infected with these viruses inevitably progress to cancer. However, the molecular reasons why the infection is controlled or instead progresses to subsequent stages of tumorigenesis are largely unknown. In this article, we provide the first complete DNA methylomes of double-stranded DNA viruses associated with human cancer that might provide important clues to help us understand the described process. Using bisulfite genomic sequencing of multiple clones, we have obtained the DNA methylation status of every CpG dinucleotide in the genome of the Human Papilloma Viruses 16 and 18 and Human Hepatitis B Virus, and in all the transcription start sites of the Epstein-Barr Virus. These viruses are associated with infectious diseases (such as hepatitis B and infectious mononucleosis) and the development of human tumors (cervical, hepatic, and nasopharyngeal cancers, and lymphoma), and are responsible for 1 million deaths worldwide every year. The DNA methylomes presented provide evidence of the dynamic nature of the epigenome in contrast to the genome. We observed that the DNA methylome of these viruses evolves from an unmethylated to a highly methylated genome in association with the progression of the disease, from asymptomatic healthy carriers, through chronically infected tissues and pre-malignant lesions, to the full-blown invasive tumor. The observed DNA methylation changes have a major functional impact on the biological behavior of the viruses.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Regulation of SNAIL1 and E-cadherin function by DNMT1 in a DNA methylation-independent context

  • Espada, Jesús
  • Peinado, Héctor
  • Renart, Jaime
  • Carrasco, Elisa
  • Calvo, María I.
  • Juarranz, Ángeles
  • Cano, Amparo
  • Esteller, Manel
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License.-- et al., Mammalian DNA methyltransferase 1 (DNMT1) is essential for maintaining DNA methylation patterns after cell division. Disruption of DNMT1 catalytic activity results in whole genome cytosine demethylation of CpG dinucleotides, promoting severe dysfunctions in somatic cells and during embryonic development. While these observations indicate that DNMT1-dependent DNA methylation is required for proper cell function, the possibility that DNMT1 has a role independent of its catalytic activity is a matter of controversy. Here, we provide evidence that DNMT1 can support cell functions that do not require the C-terminal catalytic domain. We report that PCNA and DMAP1 domains in the N-terminal region of DNMT1 are sufficient to modulate E-cadherin expression in the absence of noticeable changes in DNA methylation patterns in the gene promoters involved. Changes in E-cadherin expression are directly associated with regulation of ß-catenin-dependent transcription. Present evidence suggests that the DNMT1 acts on E-cadherin expression through its direct interaction with the E-cadherin transcriptional repressor SNAIL1., MEC (SAF2008-00609 to J.E.); MEC (SAF2007-63051 and Consolider CSD2007-00017); EU (MRTN-CT-2004-005428 to A.C.); MEC (SAF2004-07729, Consolider CSD2006-49); EU (FP7-CANCERDIP-2007-200620 to M.E.); MEC (SAF2010-19152 to J.R.). M.E. is an ICREA Research Professor. J.E. is a Ramon y Cajal Program researcher (MICIIN). Funding for open access charge: Consolider CSD2006-49 (Grant of the Spanish Science Governmental Department)., Peer Reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

CpG island hypermethylation-associated silencing of non-coding RNAs transcribed from ultraconserved regions in human cancer

  • Lujambio, Amaia
  • Portela, Anna
  • Liz, Julia
  • Melo, Sónia Rita Cardoso, 1978-
  • Rossi, Simone
  • Spizzo, Riccardo
  • Croce, Carlo M.
  • Calin, George A.
  • Esteller, Manel
Although only 1.5% of the human genome appears to code for proteins, much effort in cancer research has been devoted to this minimal fraction of our DNA. However, the last few years have witnessed the realization that a large class of non-coding RNAs (ncRNAs), named microRNAs, contribute to cancer development and progression by acting as oncogenes or tumor suppressor genes. Recent studies have also shown that epigenetic silencing of microRNAs with tumor suppressor features by CpG island hypermethylation is a common hallmark of human tumors. Thus, we wondered whether there were other ncRNAs undergoing aberrant DNA methylation-associated silencing in transformed cells. We focused on the transcribed-ultraconserved regions (T-UCRs), a subset of DNA sequences that are absolutely conserved between orthologous regions of the human, rat and mouse genomes and that are located in both intra- and intergenic regions. We used a pharmacological and genomic approach to reveal the possible existence of an aberrant epigenetic silencing pattern of T-UCRs by treating cancer cells with a DNA-demethylating agent followed by hybridization to an expression microarray containing these sequences. We observed that DNA hypomethylation induces release of T-UCR silencing in cancer cells. Among the T-UCRs that were reactivated upon drug treatment, Uc.160+, Uc283+A and Uc.346+ were found to undergo specific CpG island hypermethylation-associated silencing in cancer cells compared with normal tissues. The analysis of a large set of primary human tumors (n=283) demonstrated that hypermethylation of the described T-UCR CpG islands was a common event among the various tumor types. Our finding that, in addition to microRNAs, another class of ncRNAs (T-UCRs) undergoes DNA methylation-associated inactivation in transformed cells supports a model in which epigenetic and genetic alterations in coding and non-coding sequences cooperate in human tumorigenesis.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

A DNA methylation fingerprint of 1628 human samples

  • Fernández, Agustín F.
  • Martín-Subero, José Ignacio
  • Hidalgo, Manuel
  • Ferrer, Isidro (Ferrer Abizanda)
  • Sánchez Céspedes, Montserrat
  • Villanueva Garatachea, Alberto
  • Carmona, F. Javier
  • Sanchez-Mut, Jose Vicente
  • Berdasco, María
  • Moreno Aguado, Víctor
  • Capellá, G. (Gabriel)
  • Ballestar Tarín, Esteban
  • Pérez Jurado, Luis A.
  • Mora Graupera, Jaume
  • Puig i Sardà, Susana
  • Prat, Jaime
  • Badimón, Lina, 1953-
  • Esteller, Manel
Most of the studies characterizing DNA methylation patterns have been restricted to particular genomic loci in a limited number of human samples and pathological conditions. Herein, we present a compromise between an extremely comprehensive study of a human sample population with an intermediate level of resolution of CpGs at the genomic level. We obtained a DNA methylation fingerprint of 1628 human samples in which we interrogated 1505 CpG sites. The DNA methylation patterns revealed show this epigenetic mark to be critical in tissue-type definition and stemness, particularly around transcription start sites that are not within a CpG island. For disease, the generated DNA methylation fingerprints show that, during tumorigenesis, human cancer cells underwent a progressive gain of promoter CpG-island hypermethylation and a loss of CpG methylation in non-CpG-island promoters. Although transformed cells are those in which DNA methylation disruption is more obvious, we observed that other common human diseases, such as neurological and autoimmune disorders, had their own distinct DNA methylation profiles. Most importantly, we provide proof of principle that the DNA methylation fingerprints obtained might be useful for translational purposes by showing that we are able to identify the tumor type origin of cancers of unknown primary origin (CUPs). Thus, the DNA methylation patterns identified across the largest spectrum of samples, tissues, and diseases reported to date constitute a baseline for developing higher-resolution DNA methylation maps and provide important clues concerning the contribution of CpG methylation to tissue identity and its changes in the most prevalent human diseases
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

A DNA methylation fingerprint of 1628 human samples

  • Pérez Jurado, Luis Alberto
  • Fernández, Agustín F.
  • Esteller, Manel
Most of the studies characterizing DNA methylation patterns have been restricted to particular genomic loci in a limited number of human samples and pathological conditions. Herein, we present a compromise between an extremely comprehensive study of a human sample population with an intermediate level of resolution of CpGs at the genomic level. We obtained a DNA methylation fingerprint of 1628 human samples in which we interrogated 1505 CpG sites. The DNA methylation patterns revealed show this epigenetic mark to be critical in tissue-type definition and stemness, particularly around transcription start sites that are not within a CpG island. For disease, the generated DNA methylation fingerprints show that, during tumorigenesis, human cancer cells underwent a progressive gain of promoter CpG-island hypermethylation and a loss of CpG methylation in non-CpG-island promoters. Although transformed cells are those in which DNA methylation disruption is more obvious, we observed that other common human diseases, such as neurological and autoimmune disorders, had their own distinct DNA methylation profiles. Most importantly, we provide proof of principle that the DNA methylation fingerprints obtained might be useful for translational purposes by showing that we are able to identify the tumor type origin of cancers of unknown primary origin (CUPs). Thus, the DNA methylation patterns identified across the largest spectrum of samples, tissues, and diseases reported to date constitute a baseline for developing higher-resolution DNA methylation maps and provide important clues concerning the contribution of CpG methylation to tissue identity and its changes in the most prevalent human diseases., This work was supported by European Grants CANCER DIP HEALTH-F2-2007-200620, LSHG-CT-2006-018739-ESTOOLS, LSHC-CT-2006-037297- MCSCs, the Dr. Josef Steiner Cancer Research Foundation Award, the Fondo de Investigaciones Sanitarias Grant PI08-1345, Consolider Grant MEC09-05, the Spanish Association Against Cancer (AECC), Spanish Ministry of Education and Science (SAF2009-07319), the Lilly Foundation Biomedical ResearchAward, Fundació Cellex, and the Health Department of the Catalan Government (Generalitat de Catalunya). R.S. is supported by BMBF and Deutsche Krebshilfe. J.B. is supported in part by the University College London Cancer Institute Experimental Cancer Medicine Centre and the University College London Hospitals and University College London Comprehensive Biomedical Research Centre. M.E. is an Institució Catalana de Recerca i Estudis Avançats (ICREA) Research Professor
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer

  • Fernández, Agustín F.
  • Rosales, Cecilia
  • López Nieva, Pilar
  • Graña Castro, Osvaldo
  • Ballestar Tarín, Esteban
  • Ropero, Santiago
  • Espada, Jesús
  • Melo, Sónia Rita Cardoso, 1978-
  • Lujambio, Amaia
  • Fraga, Mario F.
  • Pino, Irene
  • Javierre, Biola M.
  • Carmona Herrera, Francisco
  • Acquadro, Francesco
  • Steenbergen, Renske D.M.
  • Snijders, Peter J. F.
  • Meijer, Chris J. L. M.
  • Pineau, Pascal
  • Dejean, Anne
  • Lloveras Rubio, Betlem
  • Capellá, G. (Gabriel)
  • Quer, Josep
  • Buti, Maria
  • Esteban, Juan I.
  • Allende, Helena
  • Rodríguez-Frías, Francisco
  • Castellsagué, Xavier
  • Minarovits, Janos
  • Ponce i Sebastià, Jordi
  • Capello, Daniela
  • Gaidano, Gianluca
  • Cigudosa, Juan Cruz
  • Gómez López, Gonzalo
  • Pisano, David G.
  • Valencia, Alfonso
  • Piris, Miguel A.
  • Bosch José, Francesc Xavier, 1947-
  • Cahir-McFarland, Ellen
  • Kieff, Elliott
  • Esteller, Manel
The natural history of cancers associated with virus exposure is intriguing, since only a minority of human tissues infected with these viruses inevitably progress to cancer. However, the molecular reasons why the infection is controlled or instead progresses to subsequent stages of tumorigenesis are largely unknown. In this article, we provide the first complete DNA methylomes of double-stranded DNA viruses associated with human cancer that might provide important clues to help us understand the described process. Using bisulfite genomic sequencing of multiple clones, we have obtained the DNA methylation status of every CpG dinucleotide in the genome of the Human Papilloma Viruses 16 and 18 and Human Hepatitis B Virus, and in all the transcription start sites of the Epstein-Barr Virus. These viruses are associated with infectious diseases (such as hepatitis B and infectious mononucleosis) and the development of human tumors (cervical, hepatic, and nasopharyngeal cancers, and lymphoma), and are responsible for 1 million deaths worldwide every year. The DNA methylomes presented provide evidence of the dynamic nature of the epigenome in contrast to the genome. We observed that the DNA methylome of these viruses evolves from an unmethylated to a highly methylated genome in association with the progression of the disease, from asymptomatic healthy carriers, through chronically infected tissues and pre-malignant lesions, to the full-blown invasive tumor. The observed DNA methylation changes have a major functional impact on the biological behavior of the viruses.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

The RNA-binding protein HuR regulates DNA methylation through stabilization of DNMT3b mRNA

  • López de Silanes, Isabel
  • Gorospe, Myriam
  • Taniguchi, Hiroaki
  • Abdelmohsen, Kotb
  • Srikantan, Subramanya
  • Alaminos, Miguel
  • Berdasco, María
  • Urdinguio, Rocío G.
  • Fraga, Mario F.
  • Jacinto, Filipe V.
  • Esteller, Manel
The molecular basis underlying the aberrant DNA-methylation patterns in human cancer is largely unknown. Altered DNA methyltransferase (DNMT) activity is believed to contribute, as DNMT expression levels increase during tumorigenesis. Here, we present evidence that the expression of DNMT3b is post-transcriptionally regulated by HuR, an RNA-binding protein that stabilizes and/or modulates the translation of target mRNAs. The presence of a putative HuR-recognition motif in the DNMT3b 3UTR prompted studies to investigate if this transcript associated with HuR. The interaction between HuR and DNMT3b mRNA was studied by immunoprecipitation of endogenous HuR ribonucleoprotein complexes followed by RTqPCR detection of DNMT3b mRNA, and by in vitro pulldown of biotinylated DNMT3b RNAs followed by western blotting detection of HuR. These studies revealed that binding of HuR stabilized the DNMT3b mRNA and increased DNMT3b expression. Unexpectedly, cisplatin treatment triggered the dissociation of the [HuR-DNMT3b mRNA] complex, in turn promoting DNMT3b mRNA decay, decreasing DNMT3b abundance, and lowering the methylation of repeated sequences and global DNA methylation. In summary, our data identify DNMT3b mRNA as a novel HuR target, present evidence that HuR affects DNMT3b expression levels post-transcriptionally, and reveal the functional consequences of the HuR-regulated DNMT3b upon DNA methylation patterns.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Regulation of SNAIL1 and E-cadherin function by DNMT1 in a DNA methylation-independent context

  • Espada, Jesús
  • Peinado, Hector
  • Lopez Serra, Lidia
  • Setién, Fernando
  • López Serra, Paula
  • Portela, Anna
  • Renart, Jaime
  • Carrasco, Elisa
  • Calvo Ademuz, Maria
  • Juarranz, Angeles
  • Cano, Amparo
  • Esteller, Manel
Mammalian DNA methyltransferase 1 (DNMT1) is essential for maintaining DNA methylation patterns after cell division. Disruption of DNMT1 catalytic activity results in whole genome cytosine demethylation of CpG dinucleotides, promoting severe dysfunctions in somatic cells and during embryonic development. While these observations indicate that DNMT1-dependent DNA methylation is required for proper cell function, the possibility that DNMT1 has a role independent of its catalytic activity is a matter of controversy. Here, we provide evidence that DNMT1 can support cell functions that do not require the C-terminal catalytic domain. We report that PCNA and DMAP1 domains in the N-terminal region of DNMT1 are sufficient to modulate E-cadherin expression in the absence of noticeable changes in DNA methylation patterns in the gene promoters involved. Changes in E-cadherin expression are directly associated with regulation of beta-catenin-dependent transcription. Present evidence suggests that the DNMT1 acts on E-cadherin expression through its direct interaction with the E-cadherin transcriptional repressor SNAIL1.